Agency Information Collection Activities; Proposed eCollection, eComments Requested; Extension Without Change of a Previously Approved Collection U.S. Official Order Forms for Schedules I and II Controlled Substances DEA Form 222, 42726 [2016-15492]
Download as PDF
42726
Federal Register / Vol. 81, No. 126 / Thursday, June 30, 2016 / Notices
INTERNATIONAL TRADE
COMMISSION
[USITC SE–16–023]
Sunshine Act Meeting
United
States International Trade Commission.
TIME AND DATE: July 8, 2016 at 11:00 a.m.
PLACE: Room 101, 500 E Street SW.,
Washington, DC 20436, Telephone:
(202) 205–2000.
STATUS: Open to the public.
MATTERS TO BE CONSIDERED:
1. Agendas for future meetings: none.
2. Minutes.
3. Ratification List.
4. Vote in Inv. Nos. 701–TA–562 and
731–TA–1329 (Preliminary)
(Ammonium Sulfate from China). The
Commission is currently scheduled to
complete and file its determination on
July 11, 2016; views of the Commission
are currently scheduled to be completed
and filed on July 18, 2016.
5. Vote in Inv. Nos. 731–TA–770–773
and 775 (Third Review) (Stainless Steel
Wire Rod from Italy, Japan, Korea,
Spain, and Taiwan). The Commission is
currently scheduled to complete and file
its determinations and views of the
Commission on July 25, 2016.
6. Outstanding action jackets: none.
In accordance with Commission
policy, subject matter listed above, not
disposed of at the scheduled meeting,
may be carried over to the agenda of the
following meeting.
AGENCY HOLDING THE MEETING:
By order of the Commission.
Issued: June 27, 2016.
William R. Bishop,
Supervisory Hearings and Information
Officer.
[FR Doc. 2016–15633 Filed 6–28–16; 11:15 am]
BILLING CODE P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
mstockstill on DSK3G9T082PROD with NOTICES
[OMB Number 1117–0010]
Agency Information Collection
Activities; Proposed eCollection,
eComments Requested; Extension
Without Change of a Previously
Approved Collection U.S. Official Order
Forms for Schedules I and II Controlled
Substances DEA Form 222
Drug Enforcement
Administration, Department of Justice.
ACTION: 60-Day notice.
AGENCY:
The Department of Justice
(DOJ), Drug Enforcement
Administration (DEA), will be
SUMMARY:
VerDate Sep<11>2014
20:01 Jun 29, 2016
Jkt 238001
submitting the following information
collection request to the Office of
Management and Budget (OMB) for
review and approval in accordance with
the Paperwork Reduction Act of 1995.
DATES: Comments are encouraged and
will be accepted for 60 days until
August 29, 2016.
FOR FURTHER INFORMATION CONTACT: If
you have comments on the estimated
public burden or associated response
time, suggestions, or need a copy of the
proposed information collection
instrument with instructions or
additional information, please contact
Courtney E. Mallon, Office of Diversion
Control, Drug Enforcement
Administration; Mailing Address: 8701
Morrissette Drive, Springfield, Virginia
22152; Telephone: (202) 598–6812.
SUPPLEMENTARY INFORMATION: Written
comments and suggestions from the
public and affected agencies concerning
the proposed collection of information
are encouraged. Your comments should
address one or more of the following
four points:
—Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
—Evaluate the accuracy of the agency’s
estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
—Evaluate whether and if so how the
quality, utility, and clarity of the
information proposed to be collected
can be enhanced; and
—Minimize the burden of the collection
of information on those who are to
respond, including through the use of
appropriate automated, electronic,
mechanical, or other forms of
information technology, e.g.,
permitting electronic submission of
responses.
Overview of this information
collection:
1. Type of Information Collection:
Extension of a currently approved
collection.
2. Title of the Form/Collection: U.S.
Official Order Forms for Schedules I
and II Controlled Substances.
3. The agency form number, if any,
and the applicable component of the
Department sponsoring the collection:
DEA Form: 222. The applicable
component within the Department of
Justice is the Drug Enforcement
Administration, Office of Diversion
Control.
PO 00000
Frm 00098
Fmt 4703
Sfmt 4703
4. Affected public who will be asked
or required to respond, as well as a brief
abstract:
Affected public (Primary): Business or
other for-profit.
Affected public (Other): Not-for-profit
institutions; Federal, State, local, and
tribal governments.
Abstract: The Controlled Substances
Act (CSA) (21 U.S.C. 801–971)
establishes a closed system of
distribution for controlled substances.
To this end, controlled substances are
closely monitored and tightly regulated
as they are distributed through the
supply chain. One tool that helps to
maintain the closed system of
distribution is the CSA provision that
states it ‘‘shall be unlawful for any
person to distribute a controlled
substance in schedules I or II to another
except in pursuance of a written order
of the person to whom such substance
is distributed, made on a form to be
issued by the Attorney General in blank
in accordance with subsection (d) of this
section..’’ 21 U.S.C. 828(a).
5. An estimate of the total number of
respondents and the amount of time
estimated for an average respondent to
respond: The DEA estimates that
125,435 registrants participate in this
information collection, taking an
estimated 11.6 hours per registrant
annually.
6. An estimate of the total public
burden (in hours) associated with the
proposed collection: The DEA estimates
the total public burden (in hours)
associated with this collection:
1,453,348 annual burden hours.
If additional information is required
please contact: Jerri Murray, Department
Clearance Officer, United States
Department of Justice, Justice
Management Division, Policy and
Planning Staff, Two Constitution
Square, 145 N Street NE., Suite 3E.405B,
Washington, DC 20530.
Dated: June 27, 2016.
Jerri Murray,
Department Clearance Officer for PRA, U.S.
Department of Justice.
[FR Doc. 2016–15492 Filed 6–29–16; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
[OMB Number 1190–0018]
Agency Information Collection
Activities; Proposed eCollection;
eComments Requested; OSC Charge
Form
Civil Rights Division,
Department of Justice.
ACTION: 30-Day notice.
AGENCY:
E:\FR\FM\30JNN1.SGM
30JNN1
Agencies
[Federal Register Volume 81, Number 126 (Thursday, June 30, 2016)]
[Notices]
[Page 42726]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-15492]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[OMB Number 1117-0010]
Agency Information Collection Activities; Proposed eCollection,
eComments Requested; Extension Without Change of a Previously Approved
Collection U.S. Official Order Forms for Schedules I and II Controlled
Substances DEA Form 222
AGENCY: Drug Enforcement Administration, Department of Justice.
ACTION: 60-Day notice.
-----------------------------------------------------------------------
SUMMARY: The Department of Justice (DOJ), Drug Enforcement
Administration (DEA), will be submitting the following information
collection request to the Office of Management and Budget (OMB) for
review and approval in accordance with the Paperwork Reduction Act of
1995.
DATES: Comments are encouraged and will be accepted for 60 days until
August 29, 2016.
FOR FURTHER INFORMATION CONTACT: If you have comments on the estimated
public burden or associated response time, suggestions, or need a copy
of the proposed information collection instrument with instructions or
additional information, please contact Courtney E. Mallon, Office of
Diversion Control, Drug Enforcement Administration; Mailing Address:
8701 Morrissette Drive, Springfield, Virginia 22152; Telephone: (202)
598-6812.
SUPPLEMENTARY INFORMATION: Written comments and suggestions from the
public and affected agencies concerning the proposed collection of
information are encouraged. Your comments should address one or more of
the following four points:
--Evaluate whether the proposed collection of information is necessary
for the proper performance of the functions of the agency, including
whether the information will have practical utility;
--Evaluate the accuracy of the agency's estimate of the burden of the
proposed collection of information, including the validity of the
methodology and assumptions used;
--Evaluate whether and if so how the quality, utility, and clarity of
the information proposed to be collected can be enhanced; and
--Minimize the burden of the collection of information on those who are
to respond, including through the use of appropriate automated,
electronic, mechanical, or other forms of information technology, e.g.,
permitting electronic submission of responses.
Overview of this information collection:
1. Type of Information Collection: Extension of a currently
approved collection.
2. Title of the Form/Collection: U.S. Official Order Forms for
Schedules I and II Controlled Substances.
3. The agency form number, if any, and the applicable component of
the Department sponsoring the collection: DEA Form: 222. The applicable
component within the Department of Justice is the Drug Enforcement
Administration, Office of Diversion Control.
4. Affected public who will be asked or required to respond, as
well as a brief abstract:
Affected public (Primary): Business or other for-profit.
Affected public (Other): Not-for-profit institutions; Federal,
State, local, and tribal governments.
Abstract: The Controlled Substances Act (CSA) (21 U.S.C. 801-971)
establishes a closed system of distribution for controlled substances.
To this end, controlled substances are closely monitored and tightly
regulated as they are distributed through the supply chain. One tool
that helps to maintain the closed system of distribution is the CSA
provision that states it ``shall be unlawful for any person to
distribute a controlled substance in schedules I or II to another
except in pursuance of a written order of the person to whom such
substance is distributed, made on a form to be issued by the Attorney
General in blank in accordance with subsection (d) of this section..''
21 U.S.C. 828(a).
5. An estimate of the total number of respondents and the amount of
time estimated for an average respondent to respond: The DEA estimates
that 125,435 registrants participate in this information collection,
taking an estimated 11.6 hours per registrant annually.
6. An estimate of the total public burden (in hours) associated
with the proposed collection: The DEA estimates the total public burden
(in hours) associated with this collection: 1,453,348 annual burden
hours.
If additional information is required please contact: Jerri Murray,
Department Clearance Officer, United States Department of Justice,
Justice Management Division, Policy and Planning Staff, Two
Constitution Square, 145 N Street NE., Suite 3E.405B, Washington, DC
20530.
Dated: June 27, 2016.
Jerri Murray,
Department Clearance Officer for PRA, U.S. Department of Justice.
[FR Doc. 2016-15492 Filed 6-29-16; 8:45 am]
BILLING CODE 4410-09-P